Our Offices - Worldwide
With our head office in Stockholm, Sweden, the organisation now spans 24 countries, delivering treatments to patients in over 60 countries across the globe. Europe is the core market for our haemophilia franchise.
Reporting of Adverse reactions:
Patient safety is a priority for Sobi. We are committed to collect, analyze and react upon any new information about the benefits and risks of our Products. If you have information about a side effect or adverse reaction associated with any of our products, please let us know via firstname.lastname@example.org.
Adverse reactions may also be reported to your national health authority as applicable according to national legislation.
For Product Complaints, please contact email@example.com.
For Medical Information, please contact your local Sobi office (please see list below) or firstname.lastname@example.org.